Medical devices, healthcare technology and the business of care
PMA approval · P060037

NEXGEN LPS-FLEX MOBILE AND LPS-MOBILE BEARING KNEE SYSTEM

Zimmer, Inc. · Decision date Dec 10, 2007

MEDTECHLEDGER EXPLANATIONP060037

What did the FDA approve?

The December 10, 2007 approval covers the Zimmer NexGen LPS-Flex Mobile and LPS-Mobile Bearing Knee System. The FDA statement lists indications for patients with severe knee pain and disability due to osteoarthritis, primary and secondary traumatic arthritis, avascular necrosis of the femoral condyle, or moderate valgus, varus, or flexion deformities. The deformities are specified as valgus/varus of 15 degrees or less and fixed flexion of 10 degrees or less.

The approval statement also says the device is intended for cemented use only. The record identifies the product code as a semi-constrained, metal/polymer, mobile bearing patellofemorotibial knee prosthesis. The database entry does not include a supplement type or supplement reason, so no additional change to an earlier PMA is described in this record.

FDA approval order statement

APPROVAL FOR THE ZIMMER NEXGEN LPS-FLEX MOBILE AND LPS-MOBILE BEARING KNEES. THESE DEVICES ARE INDICATED FOR PATIENTS WITH SEVERE KNEE PAIN AND DISABILITY DUE TO OSTEOARTHRITIS; PRIMARY AND SECONDARY TRAUMATIC ARTHRITIS; AVASCULAR NECROSIS OF THE FEMORAL CONDYLE; OR MODERATE VALGUS, VARUS, OR FLEXION DEFORMITIES (I.E., VALGUS/VARUS DEFORMITY OF <=15 DEGREES, FIXED FLEXION DEFORMITY OF <=10 DEGREES). THIS DEVICE IS INTENDED FOR CEMENTED USE ONLY.
Regulatory pathway
Original PMA
Clinical specialty
Orthopedic
Decision date
Dec 10, 2007

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P060037
Regulatory pathway
Premarket approval application
Applicant
Zimmer, Inc.
Product code
NJL
Decision code
APPR
Decision date
Dec 10, 2007
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing.

Applicant
Zimmer, Inc.
Product code
NJL
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P060037 received

    Application receipt date recorded by FDA.

  2. P060037 · FDA decision

    APPR

  3. P060037/S099 · Related supplement

    NexGen LPS-Flex Mobile and LPS-Mobile Bearing Knee System

  4. P060037/S100 · Related supplement

    NexGen LPS-Flex/LPS Mobile Bearing Knee System

Timeline entries are records held by MedtechLedger for P060037. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P060037

Product / regulatory recordCompanyPathwayDecision dateSource
Zimmer, Inc.PMA supplementSep 24, 2026FDA
Zimmer, Inc.PMA supplementOct 16, 2026FDA

Explore the linked device profile

Other records with product code NJL

Product / regulatory recordCompanyPathwayDecision dateSource
LCS Knee SystemP830055/S378
Depuy, Inc.PMA supplementOct 27, 2026FDA
Depuy, Inc.PMA supplementOct 27, 2026FDA
Depuy, Inc.PMA supplementOct 9, 2026FDA
Depuy, Inc.PMA supplementOct 8, 2026FDA
Depuy, Inc.PMA supplementOct 5, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zimmer, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
P.O. Box 708, Warsaw, IN, 46581

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records